Why the Species-to-Compartment Map Matters
A parent drug can form one or more metabolites, and a measured concentration is not automatically the amount in every modeled compartment. A PK-PD model therefore needs an explicit map: which chemical species are represented, where their amounts are tracked, how formation and elimination connect them, and which model quantity corresponds to each assay result. Ambiguity at this stage can create unit errors, double-counted losses, or a mismatch between a predicted quantity and the laboratory measurement.
The map describes model structure, not necessarily a literal anatomical picture. A “central” compartment may represent a well-mixed distribution space rather than a single physical location. A parent and its metabolite are distinct chemical species, even if both are measured in the same plasma sample. Conversely, one species may be represented in multiple modeled compartments.
Amounts, Concentrations, and Formation Links
An amount is an extensive quantity, commonly expressed in mass units such as mg or in molar units such as mmol. A concentration is amount per volume. For a well-mixed compartment with volume \(V_P\), the parent concentration is \(c_P=A_P/V_P\); the corresponding metabolite relation is \(c_M=A_M/V_M\). State the compartment and units whenever using a concentration. The volumes \(V_P\) and \(V_M\) need not be equal, even when both species are measured in plasma.
A simple linear parent–metabolite map can use first-order parent formation of metabolite \(M\), other parent elimination, and first-order metabolite elimination. In the equations below, \(k_f\), \(k_{e,P}\), and \(k_{e,M}\) have units of inverse time. \(k_f\) is the rate constant for parent disappearance through the specified metabolite-forming pathway; \(k_{e,P}\) is the rate constant for other parent loss; and \(k_{e,M}\) is the rate constant for metabolite loss. For now, take both amounts in mass units and define \(f_{M/P}\) as the mass of \(M\) formed per mass of \(P\) consumed on that pathway.
The input term has units of amount per time; for an oral dose, absorption or bioavailability may need its own representation. The parent’s loss through formation is \(k_fA_P\), while the amount of metabolite formed per time is \(f_{M/P}k_fA_P\). These rates are equal only if the mass yield is one. The yield is not automatically one because the metabolite may have a different molecular mass, and the pathway may not convert every parent molecule into the specified metabolite.
If formation is specified on a molar basis, define the amounts and yield on that basis instead. For a one-to-one molar conversion, one mole of parent consumed forms one mole of metabolite, but the resulting masses can differ. The yield basis must be consistent with the units of the state variables. For multiple pathways, each pathway’s parent loss and product formation should be represented separately, with the appropriate yield for each product.
Deriving the Balance Equations
The equations follow from amount accounting. Over a short interval \(\Delta t\), a first-order formation pathway consumes approximately \(k_fA_P\Delta t\) of parent, and other first-order elimination consumes approximately \(k_{e,P}A_P\Delta t\). Adding the parent input and dividing the net amount change by \(\Delta t\), then taking the limit as \(\Delta t\) approaches zero, gives the parent balance. The pathway forms \(f_{M/P}k_fA_P\Delta t\) of metabolite and eliminates approximately \(k_{e,M}A_M\Delta t\), yielding the metabolite balance.
This derivation assumes the pathway rates and yields are defined for the current model state, and that the first-order rate expressions are appropriate over the modeled range. A nonlinear or time-varying pathway requires a different rate expression, but the same accounting principle applies: identify each input, loss, and formation contribution once, with compatible units.
Worked Example: Mapping Parent and Metabolite States
Hypothetical model. At a particular time, the parent central compartment contains \(A_P=24.0\) mg, and the metabolite compartment contains \(A_M=8.00\) mg. Let \(V_P=12.0\) L and \(V_M=4.00\) L. Suppose \(k_f=0.150\ \text{h}^{-1}\), \(k_{e,P}=0.0500\ \text{h}^{-1}\), \(k_{e,M}=0.100\ \text{h}^{-1}\), and \(f_{M/P}=0.800\) mg \(M\) per mg \(P\). There is no parent input at this instant.
Concentrations. The parent concentration in its specified compartment is \(c_P=A_P/V_P=24.0\ \text{mg}/12.0\ \text{L}=2.00\ \text{mg/L}\). The metabolite concentration is \(c_M=A_M/V_M=8.00\ \text{mg}/4.00\ \text{L}=2.00\ \text{mg/L}\). Equal concentrations do not imply equal amounts: the amounts differ because the compartment volumes differ.
Parent balance. The total parent loss rate is \((k_f+k_{e,P})A_P=(0.150+0.0500)\ \text{h}^{-1}\times24.0\ \text{mg}=4.80\ \text{mg/h}\). Of this, \(k_fA_P=0.150\times24.0=3.60\ \text{mg/h}\) is parent consumed by the metabolite-forming pathway; the other loss is \(0.0500\times24.0=1.20\ \text{mg/h}\). Thus \(dA_P/dt=-4.80\ \text{mg/h}\).
Metabolite balance. Formation is \(f_{M/P}k_fA_P=0.800\times3.60=2.88\ \text{mg/h}\). Metabolite elimination is \(k_{e,M}A_M=0.100\times8.00=0.800\ \text{mg/h}\). Therefore \(dA_M/dt=2.88-0.800=2.08\ \text{mg/h}\). The metabolite amount is increasing at that instant, although it is also being eliminated.
Map to measurements. If separate plasma assays report parent and metabolite concentrations and the model assigns those assays to the specified central compartments, the model predictions are \(2.00\ \text{mg/L}\) for each analyte at this time. That mapping is an explicit observation assumption; it does not follow just from the fact that both compounds appear in plasma.
Yield Basis and Species Identity
A formation link must specify whether it transfers mass, moles, or a fraction of parent loss. The following example uses a one-to-one molar conversion, so a mass yield greater than one is possible without creating molecules or violating the stated stoichiometry.
Worked Example: Converting a Molar Formation Link to Mass Units
Hypothetical pathway. A parent with molecular mass \(300\ \text{g/mol}\) forms a metabolite with molecular mass \(316\ \text{g/mol}\), with one mole of metabolite formed per mole of parent consumed. The parent is consumed by this pathway at \(4.00\ \text{mg/h}\). Find the metabolite mass-formation rate and the mass yield.
Convert the parent rate to molar units. Since \(300\ \text{g/mol}=300\ \text{mg/mmol}\), \(4.00\ \text{mg/h}\div300\ \text{mg/mmol}=0.013333\ \text{mmol/h}\) of parent is consumed. The one-to-one molar stoichiometry gives the same metabolite formation rate, \(0.013333\ \text{mmol/h}\).
Convert that rate to metabolite mass: \(0.013333\ \text{mmol/h}\times316\ \text{mg/mmol}=4.213\ \text{mg/h}\), to four significant figures. Equivalently, the mass yield is \(f_{M/P}=316/300\approx1.0533\ \text{mg }M/\text{mg }P\), so using the unrounded ratio, \((316/300)\times4.00\approx4.213\ \text{mg/h}\).
The mass of metabolite exceeds the mass of parent consumed because the metabolite has a higher molecular mass; the one-to-one molar assumption is what defines the conversion here. In a model with mass amounts, using \(f_{M/P}\approx1.0533\) is appropriate. In a model with molar amounts, the one-to-one molar yield is 1. The two representations should give the same physical formation rate after unit conversion.
Observed Analytes and Observation Mapping
The assay result is an observation of an analyte, while the model state is an amount or concentration in a specified compartment. A simple direct observation model might equate a measured plasma concentration to a predicted central-compartment concentration, possibly with measurement error. That equality is an assumption about sampling, assay specificity, and the compartment representation; it is not a universal identity.
An assay can report total concentration, unbound concentration, or a signal converted to concentration by calibration. The model quantity must match that definition. If a sample contains parent and metabolite, a parent-specific assay generally reports parent rather than the sum of both species; a nonspecific assay may instead combine signals. State which situation applies. Also check whether the model predicts plasma concentration while the assay uses whole blood, or whether the reported quantity is an amount per sample rather than a concentration.
Worked Example: A Measured Metabolite With an Unmeasured Parent State
Hypothetical model and assay. A model tracks parent amount \(A_P=15.0\) mg in a central compartment of \(V_P=10.0\) L and metabolite amount \(A_M=6.00\) mg in a metabolite compartment of \(V_M=3.00\) L. The assay reports metabolite concentration in plasma only; no parent assay result is available at this time. Assume, for this example, that the plasma metabolite assay maps directly to the model metabolite compartment and that the assay is specific to \(M\).
The model parent concentration is \(15.0/10.0=1.50\ \text{mg/L}\), and the model metabolite concentration is \(6.00/3.00=2.00\ \text{mg/L}\). Under the stated mapping, the prediction to compare with the available assay is \(2.00\ \text{mg/L}\) of metabolite, not \(1.50\ \text{mg/L}\) of parent and not the sum \(3.50\ \text{mg/L}\).
The parent amount remains a modeled state because the model uses it to represent parent disposition and, if specified, metabolite formation. It is not directly observed by this assay. A metabolite-only observation therefore does not provide a direct parent concentration measurement. Whether the linked model and other data indirectly constrain parent behavior is a separate inference question; it does not change which analyte this assay reports.
If instead the assay reported total concentration of parent plus metabolite on a common mass-concentration basis, the predicted quantity under this example’s compartment assumptions would be \(1.50+2.00=3.50\ \text{mg/L}\). That sum would be inappropriate for a metabolite-specific assay.
Assumptions, Diagnostics, and Alternatives
A compartment map is interpretable only when its assumptions are explicit. The simple equations above assume well-mixed represented compartments, first-order formation and elimination, constant rate constants over the interval, and a fixed yield. They also assume that amounts are defined on a consistent basis and that every represented pathway is included once. For concentration predictions, the volume and the correspondence between model compartment and sampled matrix must be specified.
Useful checks are often structural before they are statistical. Confirm that all terms in each balance have units of amount per time; verify that parent formation loss and metabolite formation gain are connected by the declared yield; and confirm that an assay is matched to its analyte and measurement matrix. If a metabolite amount falls despite a stated formation rate greater than elimination, recheck the signs and arithmetic. If the parent equation includes the formation pathway in \(k_f\) and also includes it in a separate total-clearance term, inspect for double counting.
Common warning signs include a predicted concentration compared with a measured amount, a mass yield applied to molar state variables, a metabolite assay mapped to parent concentration, or an unexplained sum of parent and metabolite concentrations. Residual patterns can also indicate a poor structural map, but they do not by themselves establish which biological pathway is missing. The mapping should be checked against assay definitions and study design before adding complexity.
The main alternative to separate parent and metabolite states is a lumped model that represents a combined or summary quantity. A lumped model can be useful when the data cannot distinguish species or when the scientific question concerns only an aggregate measurement. It cannot, without additional assumptions, provide species-specific amounts or formation rates. An explicit species-and-compartment model makes those quantities available but requires more structural and measurement information. A further alternative is to track each species in multiple distribution compartments; this can represent distribution more fully, but it increases the number of states and connections that must be supported by data.
These choices have limits. A compartment is a mathematical representation, not proof of a physical space. A fixed yield may be inappropriate when pathways vary with concentration or time. An apparent volume should not be confused with an anatomical volume. Finally, if the observation mapping is uncertain, a precise model prediction can still be the wrong quantity to compare with the assay. The map is therefore part of the model specification, not merely a drawing convention.
Check Your Understanding
Answer each question by naming the species, state, units, and observation mapping when relevant.
- A parent amount is \(18.0\) mg in a \(9.00\)-L compartment. What is its concentration in that compartment?
- Parent formation-pathway loss is \(2.00\) mg/h and the mass yield is \(0.750\) mg metabolite per mg parent. What is the metabolite mass-formation rate?
- A metabolite-specific assay reports \(1.20\ \text{mg/L}\). Should the parent and metabolite model concentrations be added before comparison? State the condition that would justify a sum.
- In a one-to-one molar conversion, the parent mass-formation loss is \(5.00\ \text{mg/h}\), and molecular masses are \(250\ \text{mg/mmol}\) for parent and \(300\ \text{mg/mmol}\) for metabolite. Find the metabolite mass-formation rate.
Solutions. (1) \(c_P=A_P/V_P=18.0\ \text{mg}/9.00\ \text{L}=2.00\ \text{mg/L}\). (2) \(0.750\times2.00=1.50\ \text{mg/h}\) of metabolite. (3) No. Compare the result with the predicted metabolite concentration if the assay is specific to metabolite and maps to that modeled compartment. A sum is appropriate only if the assay measures the combined parent-plus-metabolite quantity and both predictions are expressed on a compatible basis. (4) Parent molar loss is \(5.00/250=0.0200\ \text{mmol/h}\). One-to-one molar conversion forms \(0.0200\ \text{mmol/h}\) of metabolite, which is \(0.0200\times300=6.00\ \text{mg/h}\).